Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Hormonal Contraception on HIV Risk
NCT02357368Phase 4Completed
- Start
- Feb 2015
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of medroxyprogesterone acetate in human immunodeficiency virus infection (HIV). Started Feb 2015; status: completed.
02
Drugs
medroxyprogesterone acetate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02357368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02357368.